Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.69
-0.17 (-0.43%)
At close: Apr 2, 2026, 4:00 PM EDT
39.58
-0.11 (-0.28%)
After-hours: Apr 2, 2026, 7:51 PM EDT
Centessa Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$42.00
Upside
+5.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 2, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $36 → $40 | Buy → Hold | Downgrades | $36 → $40 | +0.78% | Apr 1, 2026 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 31, 2026 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 31, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $40 | Buy | Initiates | $40 | +0.78% | Feb 24, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $33 → $38 | Strong Buy | Maintains | $33 → $38 | -4.26% | Jan 29, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $30 → $33 | Strong Buy | Maintains | $30 → $33 | -16.86% | Jan 8, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | -24.41% | Jan 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 → $62 | Buy | Maintains | $40 → $62 | +56.21% | Dec 10, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $33 → $42 | Strong Buy | Maintains | $33 → $42 | +5.82% | Dec 1, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $28 → $43 | Strong Buy | Maintains | $28 → $43 | +8.34% | Nov 18, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | -11.82% | Nov 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | -24.41% | Nov 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $35 | Buy | Initiates | $35 | -11.82% | Oct 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | -29.45% | Oct 6, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $31 | Buy | Initiates | $31 | -21.89% | Sep 3, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.